Funding for this research was provided by:
National Institute for Minority Health and Health Disparities (U54MD010722, U54MD010722, U54MD010722, U54MD010722)
Agency for Healthcare Research and Quality (T32HS026122)
National Cancer Institute (L60CA264691)
Received: 11 October 2022
Accepted: 2 January 2023
First Online: 7 January 2023
: The study was approved by the Vanderbilt University Institutional Review Board, and all procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.
: Written informed consent was obtained from all participants prior to their involvement.
: Informed consent included data collection and analysis. No identifying information was collected or associated with either survey or focus group responses during this study.
: The authors declare no competing interests.